✦ LIBER ✦

High incidence of infectious gastrointestinal complications observed in patients with acute myeloid leukemia receiving intensive chemotherapy for first induction of remission

✍ Scribed by Alessandra Micozzi; Claudio Cartoni; Monica Monaco; Pietro Martino; Robert Zittoun; Franco Mandelli

Publisher: Springer-Verlag
Year: 1996
Tongue: English
Weight: 338 KB
Volume: 4
Category: Article
ISSN: 0941-4355
DOI: 10.1007/bf01358883

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comorbidity is an independent predictor

Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia

✍ Anne Etienne; Benjamin Esterni; Aude Charbonnier; Marie-Joëlle Mozziconacci; Chr 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

Induction of complete remission in a pat

Induction of complete remission in a patient with acute myeloid leukemia refractory to high-dose chemotherapy through treatment with 5-azacytidine

✍ A. Kuendgen; T. Gräf; F. Zohren; B. Hildebrandt; A. Hünerlitürkoglu; N. Gatterma 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 654 KB

For patients with acute myeloid leukemia refractory to intensive chemotherapy prognosis is very poor and treatment options are limited. 5-Azacytidine, a demethylating drug, is effective in the treatment of myelodysplastic syndromes when administered at a low-dose, subcutaneously. We report a case of

Allogenic bone marrow transplantation of

Allogenic bone marrow transplantation of chemotherapy for patients with acute myeloid leukemia in first complete remission: a decision analysis approach

✍ B. Hertenstein; G. Heil; H. Heimpel 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 180 KB

Results of intensive chemotherapy in 998

Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: : Predictive prognostic models for outcome

✍ Hagop Kantarjian; Susan O'Brien; Jorge Cortes; Francis Giles; Stefan Faderl; Eli 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 1 views

## Abstract ## BACKGROUND Elderly patients (age ≥ 65 years) with acute myeloid leukemia (AML) generally have a poor prognosis. AML‐type therapy results are often derived from studies in younger patients and may not apply to elderly AML. Many investigators and oncologists advocate, at times, only s